TY - JOUR
T1 - Brachial artery diameter is related to cardiovascular risk factors and intima-media thickness
AU - Holewijn, S.
AU - Den Heijer, M.
AU - Swinkels, D. W.
AU - Stalenhoef, A. F.H.
AU - De Graaf, J.
PY - 2009/7
Y1 - 2009/7
N2 - Background Previous reports showed inconsistent results about the potential role of flow-mediated dilatation (FMD) in cardiovascular(CV) risk prediction. Few data are available about the role of nitroglycerin-mediated dilatation (NMD), but recently, brachial artery diameter(BAD) appeared to have predictive value in CV risk prediction.We determined the relation of FMD, BAD and NMD with known CV risk factors and intima-media thickness (IMT), a well-established surrogate marker of atherosclerosis, in a community-based population, the Nijmegen Biomedical Study (NBS). Materials and methods FMD, BAD and NMD were measured in the brachial, and IMT in the common carotid artery ultrasononically in 337 participants, aged 50-70 years. Traditional clinical and biochemical parameters were determined. Results Both FMD and NMD were not correlated with most CV risk factors or prevalent CVD. However, both IMT and BAD did show significant correlations with CV risk factors. In accordance, both IMT and BAD were significantly correlated with prevalent CVD (r = 0·62 and r = -0·37, respectively). Furthermore, FMD was not correlated with IMT and did hardly (R2 = 1·1%) improve the prediction of IMT by CV risk factors in regression analysis. However, both BAD and NMD did correlate with IMT (r = -0·29 and r = 0·25, respectively). Conclusion In our study, FMD and NMD were not related to known CV risk factors and prevalent CVD, and FMD was not correlated with IMT, a surrogate marker of atherosclerosis. Most intriguingly, BAD was significantly correlated with some CV risk factors, prevalent CVD and IMT. So, BAD is a potential valuable tool in CV risk prediction in middle-aged low-risk populations, whereas FMD is not.
AB - Background Previous reports showed inconsistent results about the potential role of flow-mediated dilatation (FMD) in cardiovascular(CV) risk prediction. Few data are available about the role of nitroglycerin-mediated dilatation (NMD), but recently, brachial artery diameter(BAD) appeared to have predictive value in CV risk prediction.We determined the relation of FMD, BAD and NMD with known CV risk factors and intima-media thickness (IMT), a well-established surrogate marker of atherosclerosis, in a community-based population, the Nijmegen Biomedical Study (NBS). Materials and methods FMD, BAD and NMD were measured in the brachial, and IMT in the common carotid artery ultrasononically in 337 participants, aged 50-70 years. Traditional clinical and biochemical parameters were determined. Results Both FMD and NMD were not correlated with most CV risk factors or prevalent CVD. However, both IMT and BAD did show significant correlations with CV risk factors. In accordance, both IMT and BAD were significantly correlated with prevalent CVD (r = 0·62 and r = -0·37, respectively). Furthermore, FMD was not correlated with IMT and did hardly (R2 = 1·1%) improve the prediction of IMT by CV risk factors in regression analysis. However, both BAD and NMD did correlate with IMT (r = -0·29 and r = 0·25, respectively). Conclusion In our study, FMD and NMD were not related to known CV risk factors and prevalent CVD, and FMD was not correlated with IMT, a surrogate marker of atherosclerosis. Most intriguingly, BAD was significantly correlated with some CV risk factors, prevalent CVD and IMT. So, BAD is a potential valuable tool in CV risk prediction in middle-aged low-risk populations, whereas FMD is not.
KW - Atherosclerosis
KW - Brachial artery diameter
KW - Flow-mediated dilatation
KW - Intima-media thickness
KW - Nitroglycerin-mediated dilatation
KW - Population-based
UR - http://www.scopus.com/inward/record.url?scp=66849124586&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/j.1365-2362.2009.02152.x
DO - https://doi.org/10.1111/j.1365-2362.2009.02152.x
M3 - Article
C2 - 19453648
SN - 0014-2972
VL - 39
SP - 554
EP - 560
JO - European journal of clinical investigation
JF - European journal of clinical investigation
IS - 7
ER -